Patient Capital Management's Q4 2024 investor letter showcases their successful strategy with an 8.2% return, outperforming the S&P 500. The letter discusses top holdings like CVS Health Corporation, detailing its struggles and future potential for growth.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing